Primidone Tablet
Product Images NDC 50268-686
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Primidone (NDC 50268-686). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
35fc40b2-figure-02 (35fc40b2 Figure 02)
This is a table that displays the relative risk and incidence of events for different indications of antiepileptic drugs compared to placebos. The indications include epilepsy, psychiatry, and other. The table presents information on the number of patients with events, incidence per 1000 patients, and relative risk.*
35fc40b2-figure-03 (35fc40b2 Figure 03)
250mg (Screen Shot 2014 01 28 At 8.51.20 Am)
This is a description of Primidone Tablets, USP with a strength of 250mg. It is a prescription-only medication and comes in a package of 50 tablets with a recommended dose of 5 tablets (250mg) per day. The product code is 868715. However, the text appears to be fragmented and missing some key details, making it difficult to provide a complete description.*
50mg Label (Screen Shot 2015 02 12 At 11.36.40 Am)
Primidone is a type of medication available in tablets form of 50mg strength. The tablets are available in a pack of 50 tablets with unit dosage of 5X10. The text seem to also include a reference to a Noc Sozs 8815 and an identifier code of 5026868615 and Finio. However, the last line of text is unclear and cannot be evaluated. *
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.